Vicebio (private company)
See something wrong or missing? Let us know
Offices:London
Industry:BiotechHealth services
Business model:B2B
Vicebio is a British biotech developing Molecular Clamp Technology in order to create vaccines against next-generation respiratory viruses.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 100MSecondary 16B
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Vicebio
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
57%
|
|
![]() |
Acesion Pharma
57%
|
|
![]() |
Antag Therapeutics
57%
|
|
![]() |
Arthex Biotech S.L.
57%
|
|
![]() |
Atai Life Sciences
57%
|
|
![]() |
Biofidelity
57%
|
|
![]() |
BoneSupport
57%
|
|
![]() |
CatalYm
57%
|
|
![]() |
Citryll
57%
|
|
![]() |
DeepuII
57%
|
|